Evidence map›Paper›PMID 25695625›Full record

ArticleMolecular medicine reports2015

Klotho gene delivery ameliorates renal hypertrophy and fibrosis in streptozotocin-induced diabetic rats by suppressing the Rho-associated coiled-coil kinase signaling pathway.

Minghong Deng, Yumei Luo, Yunkui Li, Qiuchen Yang, Xiaoqin Deng, Ping Wu, Houxun Ma

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Empagliflozin, SGLTNaunyn-Schmiedeberg's archives of pharmacology · 2018
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Minghong DengDepartment of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Yumei LuoDepartment of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Yunkui LiDepartment of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Qiuchen YangDepartment of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Xiaoqin DengDepartment of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Ping WuDepartment of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Houxun MaDepartment of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
First Affiliated Hospital of Chongqing Medical University · CNChongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate whether klotho gene delivery attenuated renal hypertrophy and fibrosis in streptozotocin-induced diabetic rats. A recombinant adeno-associated virus (rAAV) carrying mouse klotho full-length cDNA (rAAV.mKL), was constructed for in vivo investigation of klotho expression. Diabetes was induced in rats by a single tail vein injection of 60 mg/kg streptozotocin. Subsequently, the diabetic rats received an intravenous injection of rAAV.mKL, rAAV.green fluorescent protein (GFP) or phosphate-buffered saline (PBS). The Sprague-Dawley rat group received PBS and served as the control group. After 12 weeks, all the rats were sacrificed and ELISA, immunohistochemical and histological analyses, fluorescence microscopy, semi-quantitative reverse transcription-polymerase chain reaction and western blottin were performed. A single dose of rAAV.mKL was found to prevent the progression of renal hypertrophy and fibrosis for at least 12 weeks (duration of study). Klotho expression was suppressed in the diabetic rats, but was increased by rAAV.mKL delivery. rAAV.mKL significantly suppressed diabetes-induced renal hypertrophy and histopathological changes, reduced renal collagen fiber generation and decreased kidney hypertrophy index. In addition, rAAV.mKL decreased the protein expression levels of fibronectin and vimentin, while it downregulated the mRNA expression and activity of Rho-associated coiled-coil kinase (ROCK)I in the kidneys of the diabetic rats. These results indicated that klotho gene delivery ameliorated renal hypertrophy and fibrosis in diabetic rats, possibly by suppressing the ROCK signaling pathway. This may offer a novel approach for the long-term control and renoprotection of diabetes.

Indexed as

AnimalsDiabetes Mellitus, ExperimentalDiabetic RetinopathyFibrosisGene Expression RegulationGene Transfer TechniquesGlucuronidaseHumansHypertrophyKidneyKlotho ProteinsMiceRatsrho-Associated KinasesSignal TransductionGlucuronidaseKlotho Proteinsrho-Associated KinasesROCK1 protein, rat

Identifiers

PMID25695625
PMCPMC4438939
OpenAlexW2048393036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.